Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment

被引：0

作者：

Tabasi, Hamed ^{[1
,2
]}

Mollazadeh, Samaneh ^{[3
]}

Fazeli, Elham ^{[4
]}

Abnus, Khalil ^{[1
]}

Taghdisi, Seyed Mohammad ^{[2
]}

Ramezani, Mohammad ^{[1
,2
]}

Alibolandi, Mona ^{[1
,2
]}

机构：

[1] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Pharmaceut Res Ctr, Mashhad, Iran

[2] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Mashhad, Iran

[3] North Khorasan Univ Med Sci, Nat Prod & Med Plants Res Ctr, Bojnurd, Iran

[4] Aarhus Univ, Biomed Dept, Aarhus, Denmark

来源：

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY | 2024年 / 196卷 / 03期

关键词：

Oligonucleotide; siRNA; miRNA; mRNA; Cancer-therapy; Immunotherapy; MESOPOROUS SILICA NANOPARTICLES; TARGETED SIRNA DELIVERY; CO-DELIVERY; STAT3; SIRNA; MIRNA OLIGONUCLEOTIDE; EFFICIENT DELIVERY; DOWN-REGULATION; DRUG-DELIVERY; COLON-CANCER; LUNG-CANCER;

D O I：

10.1007/s12010-023-04597-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Conventional cancer therapies with chemodrugs suffer from various disadvantages, such as irreversible side effects on the skin, heart, liver, and nerves with even fatal consequences. RNA-based therapeutic is a novel technology which offers great potential as non-toxic, non-infectious, and well-tolerable platform. Herein, we introduce different RNA-based platforms with a special focus on siRNA, miRNA, and mRNA applications in cancer treatment in order to better understand the details of their therapeutic effects. Of note, the co-delivery of RNAs with other distinct RNA or drugs has provided safe, efficient, and novel treatment modalities for cancer treatment. [GRAPHICS] .

引用

页码：1685 / 1711

页数：27

共 50 条

[1] Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment
Hamed Tabasi
Samaneh Mollazadeh
Elham Fazeli
Khalil Abnus
Seyed Mohammad Taghdisi
Mohammad Ramezani
Mona Alibolandi
Applied Biochemistry and Biotechnology, 2024, 196 : 1685 - 1711
[2] Insight into RNA-based Therapies for Ovarian Cancer
Keyvani, Vahideh
Mahmoudian, Reihaneh Alsadat
Mollazadeh, Samaneh
Kheradmand, Nahid
Ghorbani, Elnaz
Khazaei, Majid
Al-Hayawi, Ibrahim Saeed
Hassanian, Seyed Mahdi
Ferns, Gordon A.
Avan, Amir
Anvari, Kazem
CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (34) : 2692 - 2701
[3] Peptide and RNA-based vaccines for the treatment of cancer
Mackensen, A.
ONKOLOGIE, 2011, 34 : 202 - 202
[4] Theranostic Nanoparticles for RNA-Based Cancer Treatment
Revia, Richard A.
Stephen, Zachary R.
Zhang, Miqin
ACCOUNTS OF CHEMICAL RESEARCH, 2019, 52 (06) : 1496 - 1506
[5] RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
Bajan, Sarah
Hutvagner, Gyorgy
CELLS, 2020, 9 (01)
[6] DNA/RNA-based formulations for treatment of breast cancer
Xie, Zhaolu
Zeng, Xianghui
EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (12) : 1379 - 1393
[7] RNA-based cancer strategy
不详
R&D MAGAZINE, 2005, 47 (09): : 19 - 19
[8] The Potential Use of RNA-based Therapeutics for Breast Cancer Treatment
Song, Yangyang
Ke, Xinyu
Chen, Leilei
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (25) : 5110 - 5136
[9] RNA-Based Vaccines in Cancer Immunotherapy
McNamara, Megan A.
Nair, Smita K.
Holl, Eda K.
JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
[10] RNA-based therapeutic strategies for cancer
Read, ML
Stevenson, M
Farrow, PJ
Barrett, LB
Seymour, LW
EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (05) : 627 - 638

← 1 2 3 4 5 →